alea-institute/kl3m-data-sample-004-shuffled huggingface dataset:
No. 10-10981.

#### Timothy Lee Wilson, Petitioner v. United States.

565 U.S. 860, 132 S. Ct. 198,

181 L. Ed. 2d 104,

2011 U.S. LEXIS 6077.

October 3, 2011.

Petition for writ of certiorari to the United States Court of Appeals for the Eighth Circuit denied.

Same case below, 411 Fed. Appx. 938.
UN PUBLISHED
UNITED STATES COURT OF APPEALS FOR THE FOURTH CIRCUIT

No. 17
- 6887

UNITED STATES OF AMERICA , Plaintiff

- Appellee ,

v. MELVIN MOORING , Defendant

- Appellant

.

Appeal from the United States District Court for the Eastern District of Virginia , at Alexandria

. Liam O’Grady , District Judge. ( 1:13

- cr
- 00092

- LO

- 1 ; 1:16

- cv
- 00437

- LO )

Submitted : November 16, 2017 Decided: November 21, 2017

Before GREGORY, Chief Judge, and TRAXLER and KEENAN , Circuit Judges.

Dismissed by un published per curiam opinion

.
Melvin Mooring , Appellant Pro Se. Caitlin Roberts Cottingham, Assistant U nited S tates Attorney , Washington, D.C., for Appellee.

Unpublished opinions are not binding precedent in this circuit.2 PER CURIAM:
Melvin M ooring seeks to appeal the district court’s order denying relief on his 28 U.S.C. § 2255 (2012) motion. We dismiss the appeal for lack of jurisdiction because the notice of appeal was not timely filed. When the United States or its officer or agency is a party, the notice of appeal must be filed no more than 60 days after the entry of the district court's final judgment or order, Fed. R. App. P. 4(a)(1)(B), unless the district court extends the appeal period under Fed. R. App. P. 4(a)(5), or reopens the ap peal period under Fed. R. App. P. 4(a)(6). “[T]he timely filing of a notice of appeal in a civil case is a jurisdictional requirement.”
Bowles v. Russell , 551 U.S. 205, 214 (2007). The district court's order was entered on the
docket on August 11, 2016 . T he notice of appeal was filed, at the earliest, on June 20,
2017. * Because Mooring failed to file a timely notice of appeal or to obtain an extension or reopening of the appeal period, we dismiss the appeal. We deny Mooring’s motion for leave to proceed in forma pauperis and we dispense with oral argument because the facts and legal contentions areadequately presented in the materials before this court and argument would not aid the decisional process.
DISMISSED

* For the purpose of this appeal, we assume that the date appearing on the notice of appeal is the earliest date it could have been properly delivered to prison officials for mailing to the court. Fed. R. App. P. 4(c); Houston v. Lack , 487 U.S. 266, 276 (19 88).
***************************

 * MONOGRAPH NO: 1A1E

***************************

ITEM: Vegetable Lasagna (VLA) (PRIMARY)

NSN: 8940-01-484-9655 ITEM SPECIFICATION: PCR-V-001 Can

 8940-01-484-9642 PCR-V-002 Poly

CHARACTERISTICS OF ITEM:

APPEARANCE: light tan lasagna noodles with vegetables (peppers, onion, 

tomatoes, carrots, spinach) and tan cheese, in tomato sauce

ODOR: tomato sauce; cooked pasta; Italian seasoning; cooked cheese

FLAVOR: Italian seasoning; onion; garlic; cooked pasta; tomato sauce

TEXTURE: pasta shall be slightly firm to slightly soft; slightly stringy cheese

ESTIMATED SHELF-LIFE AT: 80 DEGREES F: 36m

 100 DEGREES F: 6m

POSSIBLE DETERIORATIVE CHANGES:

Appearance: darkening of all components

Odor: burnt; scorched, loss of Italian seasoning

Flavor: scorched; loss off Italian seasoning, onion, garlic, tomato

Texture: pasta too soft; vegetables too soft; drier chewier cheese; thickening 

of overall product

UNIQUE EXAMINATION/TEST PROCEDURES: None
**Exhibit
32**
 
 
 **Certification
by the Chief Executive Officer Pursuant to 18 U. S. C. Section 1350, as
Adopted**
 **Pursuant
to Section 906 of the Sarbanes-Oxley Act of 2002**
 
 Pursuant
to 18 U. S. C. Section 1350, I, Arnold S. Lippa, hereby certify that, to
the best of my knowledge, the Quarterly Report on Form 10-Q of DOV
Pharmaceutical, Inc. for the quarter ended March 31, 2005 (the “Report”) fully
complies with the requirements of Section 13(a) or Section 15(d) of
the Securities Exchange Act of 1934, and that the information contained in the
Report fairly presents, in all material respects, the financial condition and
results of operations of DOV Pharmaceutical, Inc.
 
 A signed
original of this written statement required by Section 906 has been provided to
DOV and will be retained by DOV and furnished to the Securities and Exchange
Commission or its staff upon request.
 
 /s/
Arnold S. Lippa
 
 Arnold S.
Lippa
 Chairman
of the Board, Chief Executive Officer and President
 May 9,
2005
 
 **Certification
by the Chief Financial Officer Pursuant to 18 U. S. C. Section 1350, as
Adopted**
 **Pursuant
to Section 906 of the Sarbanes-Oxley Act of 2002**
 
 Pursuant
to 18 U. S. C. Section 1350, I, Barbara Duncan, hereby certify that, to the
best of my knowledge, the Quarterly Report on Form 10-Q of DOV
Pharmaceutical, Inc. for the quarter ended March 31, 2005 (the “Report”) fully
complies with the requirements of Section 13(a) or Section 15(d) of
the Securities Exchange Act of 1934, and that the information contained in the
Report fairly presents, in all material respects, the financial condition and
results of operations of DOV Pharmaceutical, Inc.
 
 A signed
original of this written statement required by Section 906 has been provided to
DOV and will be retained by DOV and furnished to the Securities and Exchange
Commission or its staff upon request.
 
 /s/ Barbara
Duncan
 
 Barbara
Duncan
 Chief
Financial Officer
 May 9,
2005
 
 These
certifications accompany this Report on Form 10-Q pursuant to
Section 906 of the Sarbanes-Oxley Act of 2002 and shall not, except to the
extent required by such Act, be deemed filed by the Company for purposes of
Section 18 of the Securities Exchange Act of 1934, as amended. Such
certification will not be deemed to be incorporated by reference into any filing
under the Securities Act of 1933, as amended, or the Securities Exchange Act,
except to the extent that the Company specifically incorporates it by
reference.
No. 11-6633.

#### Michael Paul Bradley, Petitioner v. Donald Barrow, Warden.

565 U.S. 1081, 132 S. Ct. 817,

181 L. Ed. 2d 529,

2011 U.S. LEXIS 8724.

December 5, 2011.

Petition for writ of certiorari to the United States Court of Appeals for the Eleventh Circuit denied.
**Exhibit 35.1**

 

ANNUAL SERVICER’S COMPLIANCE CERTIFICATE

 

This Compliance Certificate is furnishedpursuant to Section 4.10 of the Sale and Servicing Agreement (the “Agreement”), dated as of August 16, 2017, by andamong Hyundai Auto Receivables Trust 2017-B, Hyundai Capital America, as seller and servicer (the “Servicer”), HyundaiABS Funding, LLC, as depositor, and Citibank, N.A., as indenture trustee and Item 1123 of Regulation AB. The undersigned herebycertifies that:

 

1)       I am a duly authorizedofficer of the Servicer.

 

2)       A review of theactivities of the Servicer from January 1, 2018 through December 31, 2018 (the “Relevant Period”) and of the Servicer’sperformance under the Agreement during the Relevant Period has been made under my supervision.

 

3)       Based on such review,the Servicer has, to the best of my knowledge, fulfilled all of its obligations under the Agreement in all material respects throughoutthe Relevant Period.

 

IN WITNESS WHEREOF, I have duly executed this Compliance Certificatethis 15th day of March, 2019.
```
[Federal Register Volume 63, Number 17 (Tuesday, January 27, 1998)]
[Notices]
[Page 3906]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 98-2023]

-----------------------------------------------------------------------

DEPARTMENT OF HEALTH AND HUMAN SERVICES

Food and Drug Administration

Food Advisory Committee; Notice of Meeting

AGENCY: Food and Drug Administration, HHS.

ACTION: Notice.

-----------------------------------------------------------------------

    This notice announces a forthcoming meeting of a public advisory 
committee of the Food and Drug Administration (FDA). The meeting will 
be open to the public.
    Name of Committee: Food Advisory Committee.
    General Function of the Committee: To provide advice and 
recommendations to the agency on FDA regulatory issues.
    Date and Time: The meeting will be held on February 11, 12, and 13, 
1998, 8:30 a.m. to 5 p.m.
    Location: DoubleTree Hotel, Pentagon City, 300 Army Navy Dr., 
Arlington, VA.
    Contact Person: Catherine M. DeRoever, Center for Food Safety and 
Applied Nutrition (HFS-22), Food and Drug Administration, 200 C St. 
SW., Washington, DC 20204, 202-205-4251, FAX 202-205-4970, E-mail 
[email protected], or FDA Advisory Committee Information Line, 
1-800-741-8138 (301-443-0572 in the Washington, DC area), code 10564. 
Please call the Information Line for up-to-date information on this 
meeting.
    Agenda: On February 11, 12, and 13, 1998, the committee will 
undertake discussions on dietary supplements. Issues raised in the 
report of the White House Commission on Dietary Supplement Labeling 
relating to postmarket surveillance and consumer research will be 
discussed. Also, two aspects relating to good manufacturing practices 
(GMP's) for dietary supplements will be addressed. The agency is 
interested in recommendations for ensuring the identity for different 
types of dietary ingredients and on recordkeeping requirements. On 
February 13, 1998, two committee working groups will continue 
discussing assignments stemming from the Keystone report on health 
claims.
    Procedure: Interested persons may present data, information, or 
views, orally or in writing, on issues pending before the committee. 
Written submissions may be made to the contact person by February 9, 
1998. Oral presentations from the public will be scheduled between 
approximately 4 p.m. and 5 p.m. on February 11 and 12, 1998. Time 
allotted for each presentation may be limited. Those desiring to make 
formal oral presentations should notify the contact person before 
February 9, 1998, and submit a brief statement of the general nature of 
the evidence or arguments they wish to present, the names and addresses 
of proposed participants, and an indication of the approximate time 
requested to make their presentation.
    Notice of this meeting is given under the Federal Advisory 
Committee Act (5 U.S.C., app. 2).

    Dated: January 22, 1998.
Michael A. Friedman,
Deputy Commissioner for Operations.
[FR Doc. 98-2023 Filed 1-23-98; 11:47 am]
BILLING CODE 4160-01-F
```
************************

• MONOGRAPH NO.: 1C9

************************

ITEM: Waffles, Plain, Shelf Stable (WPL)

NSN: 8920 01 368 3592 ITEM SPECIFICATION: CID A A 20234

CHARACTERISTICS OF ITEM:

APPEARANCE: golden brown surface, light yellow interior; square waffle

marks/indentations

ODOR: sweet vanilla; caramelized

FLAVOR: sweet vanilla; caramelized

TEXTURE: soft; slightly chewy/spongy

ESTIMATED SHELF-LIFE AT: 80 DEGREES F: 36 months

 100 DEGREES F: 6 months

POSSIBLE DETERIORATIVE CHANGES:

Appearance: darkening; off-color

Odor: staling; loss of odor; rancid

Flavor: dull, loss of flavor; staling; rancid

Texture: chewy, dry; hardening

UNIQUE EXAMINATION/TEST PROCEDURES: none
UNPUBLISHED

UNITED STATES COURT OF APPEALS

FOR THE FOURTH CIRCUIT

No. 03-7380

JAMES A. BUTLER,

 Plaintiff - Appellant,

 versus

FEDERAL BUREAU OF PRISONS; UNITED STATES

DEPARTMENT OF JUSTICE; FEDERAL CORRECTIONAL

INSTITUTE, CUMBERLAND; WARDEN SHEARIN; UNITED

STATES OF AMERICA,

 Defendants - Appellees.

Appeal from the United States District Court for the District of

Maryland, at Baltimore. William M. Nickerson, Senior District

Judge. (CA-03-797-1-WMN)

Submitted: July 21, 2004 Decided: August 12, 2004

Before WIDENER, WILLIAMS, and KING, Circuit Judges.

Affirmed by unpublished per curiam opinion.

James A. Butler, Appellant Pro Se. Thomas Michael DiBiagio, United

States Attorney, Baltimore, Maryland; Matthew Wayne Mellady, UNITED

STATES DEPARTMENT OF JUSTICE, Annapolis Junction, Maryland, for

Appellees.

Unpublished opinions are not binding precedent in this circuit.

See Local Rule 36(c).
- 2 -

PER CURIAM:

James A. Butler filed suit under the Federal Tort Claims

Act, seeking damages for the loss of his legal materials.

Defendants filed a motion for summary judgment, and although warned

of the consequences, Butler failed to respond. The district court

granted the motion, and Butler appeals. After a thorough review of

the record, we find that Butler failed to demonstrate a genuine

issue of material fact for trial. As the non-moving party, Butler

could not rely upon the mere allegations of his complaint. Since

he failed to respond with affidavits or other verified evidence,

summary judgment was appropriately entered against him. See Fed.

R. Civ. P. 56; Celotex Corp. v. Catrett, 477 U.S. 317, 323 (1986).

Accordingly, we affirm. We deny Butler’s motion to appoint

counsel. We dispense with oral argument because the facts and

legal contentions are adequately presented in the materials before

the court and argument would not aid the decisional process.

AFFIRMED
ID Descriptor L* a* b* c h dL* da* db* dEcmc*

Standard 3950 STANDARD 46.85 0.71 12.94

Tolerance

1

2

3

4

5

6

7

8

9

COMMENTS: NUMBERS ARE FOR REFERENCE ONLY 

Equipment Type HUNTER ULTRA SCAN PRO Setting Mode: Specular Included - 

Reflectance

UV Filter – OUT UV Lamp OFF

DLA/ARMY SHADE TOLERANCE PROJECT April 3, 2019

Fabric Nomenclature CLOTH, FLEECE, INSULATED AND FLAME 

RESISTANT, MIDWEIGHT GL-PD-12-13B

Shade Number TAN 499 Piece/Roll Number 3950
M14007

Part II, Section A.2 and A.3

– Industrial Sites Controlled by Submitter Occupational Exposure and Environmental Release and Disposal Page 1 of 1

SiVance LLC

The PMN substance will be manufactured at SiVance LLC

. Because it is used only as a site

- limited intermediate, e xposure of workers may occur only during the manufacturing process.



## Manufacture Exposure

During manufacture, workers may be exposed while sampling ( worker activity A) , testing ( worker activity B) and transferring (worker activity C & D )

. There is expected to be one operator samplin g the reaction vessel, working 3 0 minutes

, 8 times per year, one operator analyzing the P MN substance, working 30 minutes

, 8 times per year, one operator transferring the PMN substance for redistillation, working 1 hour, 8 times per year, and one operator transferring the PMN s ubstance for next reaction step , working 1 hour

, 8 times per year

.

The PMN sub stan ce will be manufactured in 2

- batch campaigns, 4 time s per year. The e mpty reactor
vessel is washed with xylenes, gravity drained and sent to an off

- site incineration facility (Release 1 ).
The PMN substance will be transferred from a portable holding tank to a reactor vessel for use in a subsequent reaction step. The empty portable holdi ng tank is washed with xylenes, which is collected
and sent to an off

- site incineration facility (Release 2). The portable holding tank is then reused in the

same process. Worker Activity A

Sample PMN substance from reaction

vessel. Worker Activity B

Analyze PMN substance from reaction

vessel.

Worker Activity C

Transfer of PMN substance to reactor
vessel for redistillation

. Worker Activity D

T ransfer of PMN substance to and

from portable holding tank.

Release 1

The PMN substance will be manu factured

in 2

- batch campaigns, 4 times per year.

The e mpty reactor vessel is washed with xylenes, gravity drained and sent to an off

site incineration facility. Release 2

The PMN substance will be transferred to
and from a portable holding tank to a

reactor vessel for use in a sub sequent reaction step.

The empty portable holding tank is washed with xylenes, which is collected and sent
to an off

- site incineration facility. The portable holding tank is then reused in the

same process.



### CONFIDENTIAL CONFIDENTIAL
No. 11-7061.

#### James R. Smith, Petitioner v. Michelle R. Ricci, Administrator, New Jersey State Prison, et al.

565 U.S. 1122, 132 S. Ct. 1023,

181 L. Ed. 2d 754,

2012 U.S. LEXIS 182.

January 9, 2012.

Petition for writ of certiorari to the United States Court of Appeals for the Third Circuit denied.
No. 11-516.

#### Chukwujindu Victor Mbakpuo, Petitioner v. Eric H. Holder, Jr., Attorney General.

565 U.S. 1113, 132 S. Ct. 1017,

181 L. Ed. 2d 737,

2012 U.S. LEXIS 408,

January 9, 2012.

Petition for writ of certiorari to the United States Court of Appeals for the Fourth Circuit denied.

Same case below, 439 Fed. Appx. 235.
ID Descriptor L* a* b* c h dL* da* db* dEcmc*

Standard 3946 STANDARD 24.30 7.93 7.81

Tolerance

1 3946A YELLOW LIMIT 23.76 8.76 9.41 -0.54 0.83 1.60 1.66

2

3

4

5

6

7

8

9

COMMENTS: NUMBERS ARE FOR REFERENCE ONLY 

Equipment Type HUNTER ULTRA SCAN PRO Setting Mode: Specular Included - 

Reflectance

UV Filter – OUT UV Lamp OFF

Shade Number SIERRA BROWN 569 Piece/Roll Number 3946

DLA/ARMY SHADE TOLERANCE PROJECT June 16, 2019

Fabric Nomenclature BERET, 100% WOOL CR-PD 01-09
ARMED SERVICES BOARD OF CONTRACT APPEALS Appeals of

-- ) ) VLOX, LLC ) ) ) Under Contract No. W91B4N-09-D-5005 ) APPEARANCES FORTHE APPELLANT:

APPEARANCES FORTHE GOVERNMENT: ASBCA Nos. 59305, 59306, 59307 59308,59309,59310
Joseph A. Artabane, Esq.

Artabane & Belden, P.C. Washington, DC Billy B. Ruhling, II, Esq.

DiMuroGinsberg, P.C. Alexandria, VA Raymond M. Saunders, Esq.

Army ChiefTrial Attorney Frank A. March, Esq.

Trial Attorney ORDER OF DISMISSAL The dispute has been settled. The appeals are dismissed with prejudice. Dated: 8 March 2016

# ~~ Administrative Judge Armed Services Board ofContract AppealsI certify that the foregoing is a true copy ofthe Order ofDismissal ofthe Armed Services Board ofContract Appeals in ASBCA Nos. 59305, 59306, 59307, 59308, 59309, 59310, Appeals ofVLOX, LLC, rendered in conformance with the Board's Charter. Dated:

2 JEFFREY D. GARDIN Recorder, Armed Services Board ofContract Appeals
Exhibit 35.2

SERVICER COMPLIANCE STATEMENT

In connection with the Annual Report on Form 10-K of Drive Auto Receivables Trust 2017-2 for the fiscal year ended December 31, 2017 (the Report), the undersigned, a duly authorized officer of Santander Consumer International Puerto Rico LLC (the Subservicer), does
hereby certify and represent that:



| | 1. | A review of the activities and performance of the Subservicer under the Sale and Servicing Agreement, dated as of July 31, 2017, among Santander Drive Auto Receivables LLC, Santander Consumer USA Inc., Drive Auto
Receivables Trust 2017-2 and Wilmington Trust, National Association (the Agreement) during the period that is the subject of the Report has been made under my supervision.
| | -- | --------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------



| | 2. | A review of the activities and performance of the Subservicer under the Servicing Agreement, dated July 15, 2016 (the Servicing Agreement), by and between Santander Consumer USA Inc. and Santander
Consumer International Puerto Rico LLC, and the related Second Amended and Restated Program Portfolio Schedule (Publicly Registered Transactions), dated as of June 28, 2017 (the Second Amended and Restated Program Portfolio Schedule, together
with the Servicing Agreement, the Subservicing Agreement), during the period that is the subject of the Report has been made under my supervision.
| | -- | --------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------



| | 3. | To the best of my knowledge, based on such review, the Subservicer has fulfilled all of its obligations under the Agreement and the Subservicing Agreement in all material respects throughout the period that is the
subject of the Report.
| | -- | --------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------



SANTANDER CONSUMER INTERNATIONAL PUERTO RICO LLCBy:

/s/ Jose RamirezName:

Jose RamirezTitle:

Vice President of Servicing for Santander Consumer International Puerto Rico, LLCDate:

March 30, 2018
Unassociated Document



Exhibit 10.7




 


Lilis Energy, Inc.


1900 Grant Street, Suite 720


Denver, CO 80203







April 29, 2014


 


T.R. Winston & Company, LLC


1999 Avenue of the Stars, Suite 2550


Log Angeles, CA  90067


Attention: Tyler Runnels and Karen Ting







Re:           Transaction Fee Agreement, dated March 28, 2014 (the “Agreement”)







Dear Sir or Madam:







As discussed, this letter, when executed in the space indicated below, shall constitute our amendment to the above-referenced Transaction Fee Agreement between Lilis Energy, Inc. and T.R. Winston & Company, LLC.







In consideration of our mutual efforts to pursue the transactions contemplated by the Transaction Fee Agreement, we hereby agree that Section 1 of the letter shall be amended and restated in its entirety as follows:







1.           The Company agrees to compensate the Broker as follows: (i) eight percent (8%) of the gross proceeds of the offering, payable at the Closing (as defined in the Purchase Agreement), (ii) one percent (1%) of the gross proceeds received by the Company at Closing, payable at Closing, for a non-accountable expense allowance, and (iii) shall reimburse the agent for its legal fees and expenses equal to $25,000.







The remaining terms and conditions of the Agreement shall continue in full force and effect.







If the foregoing meets your agreement, please execute a copy of this letter agreement in the space indicated below and return one original to the undersigned.


 




	  	
Lilis Energy, Inc.


	  	  	  
	  	
By:

	
/s/ A. Bradley Gabbard


	  	
Name:

	
A. Bradley Gabbard


	  	
Title:

	
Chief Financial Officer









 



Agreed and Accepted:


 




	
T.R. Winston & Company, LLC

	 
	  	  	 
	
By:

	
/s/ G. Tyler Runnels

	 
	
Name:

	
G. Tyler Runnels

	 
	
Title:

	
Chairman & CEO
No. 11-6744.

#### Philip D. Rossi, Petitioner v. United States.

565 U.S. 1019, 132 S. Ct. 563,

181 L. Ed. 2d 406,

2011 U.S. LEXIS 8024.

November 7, 2011.

Petition for writ of certiorari to the United States Court of Appeals for the Sixth Circuit denied.

Same case below, 422 Fed. Appx. 425.